Gentamicin/Vancomycin

庆大霉素/万古霉素

Report date: 2022/07/04 19:38:02
QIDP

Base Information

Drug NameGentamicin/Vancomycin
Drug Alias NameVancomycin/gentamicinXimycinDFA-02
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsCell wall inhibitorsPeptidoglycan inhibitors
TargetsPeptidoglycan30S ribosomal subunit
Therapy Area/IndicationsSurgical Wound Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Gentamicin SulfateVancomycin Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDuke Clinical Research InstituteDr.Reddy's Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke Clinical Research InstituteDr.Reddy's Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsSurgical Wound Infection

Other Information

ATC CodeN/A
Related LinksN/A